Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3213 participants
OBSERVATIONAL
2000-01-31
2002-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sex Steroids, Obesity and Lipids in Adolescent Females
NCT00005210
Breaking Sitting and Metabolic Health in Sedentary Lean Adults
NCT05306613
Sex Hormones as Regulators of the Age- and Sex-dependent Benefits of Caloric Restriction
NCT07065643
Weight Set-Point and HDL Concentration in Runners
NCT00005342
Breaking Sitting and Metabolic Health in Sedentary Overweight and Obese Adults
NCT05306678
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
3161 men (45-84 years old)
3161 men without known coronary artery disease
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* African American
* Caucasian
* Asian (largely Chinese) and Hispanic adults aged 45-84 years and free of known cardiovascular disease at baseline (2000-2002)
Exclusion Criteria
45 Years
84 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gulhane School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aydogan Aydogdu
MD
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AA1972
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.